Home » Illumina

Illumina

Illumina is a developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. Illumina has developed a line of DNA sequencing technology products that address the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests.

Illumina Company Profile 

 

President & CEO: Francis deSouza

CEO photo:

illumina CEO Francis deSouza photo

Website: www.illumina.com

Ticker symbol: ILMN

Headquarters: San Diego, CA

Illumina employees: 5,500+ globally

Revenues: $2.4 Billion USD in 2016

Founded: 1998

Founders: Larry Bock, Anthony Czarnik, David Walt, Mark Chee, John Stuelpnagel

 

Illumina News 

Oct 08, 2018

Investors Sue Illumina for Fraud in Connection With Q3 2016 Earnings Results

Two investors are alleging Illumina committed fraud through artificial inflation of stock price in connection with its Q3 2016 earnings.

Oct 04, 2018

Illumina Looking to Raise Profile in Genome Informatics

Premium

The sequencing giant is migrating its BaseSpace analytics products to AWS in hopes of simplifying user adoption and rapidly expanding its library of curated content.

Sep 20, 2018

Chinese DTC Genomics Firm WeGene Plans to Go International, Expand Cohort Research

Premium

The Shenzhen-based company offers personal genomics services in China that are similar to those provided by 23andMe, Ancestry, and Helix in the US.

Sep 19, 2018

Premaitha Licenses NIPT Tech From Illumina Under Settlement

By early 2020, the UK company plans to develop a version of its Iona test that uses Illumina's sequencing technology.

Sep 05, 2018

Gene Editing Company Inscripta Acquires Solana Biosciences

Solana, founded in 2017 by former Illumina employees, has launched hundreds of products, including DNA sequencing solutions.

Aug 29, 2018

New York to Reduce TB Susceptibility Testing Based on Whole-Genome Sequencing Data

Premium

NYSDOH's move away from susceptibility testing for isolates that are known to be pan-susceptible will be coordinated with similar international efforts.

Aug 27, 2018

Illumina Secures China National Drug Administration Clearance for MiSeqDx System

Illumina can now sell the instrument in China for IVD purposes. The firm said that the system is its first CNDA-cleared NGS platform in China.

Aug 17, 2018

Illumina Prices Senior Notes Offering

Funds raised through the offering will be used to buy back shares of common stock from shareholders in privately negotiated transactions.

Aug 15, 2018

Illumina Launches $650M Senior Notes Offering

Initial purchasers will also have a 30-day option to purchase up to an addition $100 million of the notes for a potential offering size of $750 million.

Aug 06, 2018

Lawsuit Against Illumina, Thermo Fisher, Others Alleges Fraud, Theft of Trade Secrets

The lawsuit makes broad accusations that companies stole trade secrets related to universal array technology.

Pages

The Scan

Warren Releases Genetic Ancestry Results

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Thirty-One Recommended for Removal

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz Dies

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

This Week in PLOS

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.